Femalto oral solution 30ml CPC1HN supplemented with liquid organic iron

Dosage form Solution
Specifications Box
Ingredient Iron (III) Hydroxyd Polymaltose

Ingredient

Thành phần cho 1ml

Composition information	Content
Iron (III) Hydroxyd Polymaltose	50mg

Uses

Indications

Femalto oral solution used in the treatment of iron deficiency without anemia and iron deficiency accompanied by anemia for patients at risk such as:

Pregnant women.

breastfeeding women. B03ab05

Mechanism: Iron is the material to form hemoglobin.

iron absorbed is mainly stored in the liver, where it is linked to ferritin. Then it is integrated in the bone marrow into the hemoglobin.

pharmacokinetics

absorption, distribution

The ratio of absorption or iron is associated with hemoglobin inversely proportional to the dose. The amount of iron absorbed depends on the level of iron deficiency (the higher the iron deficiency is the higher the ability to absorb). Using drugs in treatment, the absorption rate is about 10%. The drug is absorbed in the small intestine especially in the nodes and duodenum.

Metabolism and elimination

iron does not absorb excretion through feces.

Before taking Femalto oral solution 30ml CPC1HN supplemented with liquid organic iron

How to use

can mix femalto with fruit juice, vegetable juice or bottled water. Can be used once a day or many times/day.

1 ml corresponds to 14 drops.

Dosage

Dosage and treatment time depend on the level of iron deficiency:

Object iron deficiency with anemia iron deficiency without anemia (ml/drops)

(7-14 drops)

15 - 25

0.5

(7 drops)

(14 - 28 drops)

25 - 50

0.5 - 1

(7 - 14 drops)

(28 - 84 drops)

50 - 100

1 - 2

(14 - 28 drops)

In case of significant signs of iron deficiency, it is necessary to treat for about 3-5 months until the value of hemoglobin returns to normal. After that, it is necessary to continue treating for a few weeks with indications for potential iron deficiency to supplement the amount of iron reserves.

The hidden iron deficiency treatment time is not accompanied by anemia lasting 1-2 months.

Specific dose depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose?

The comparative studies between iron (II) sulfate and iron (III) Hydroxyd polymaltose on the mouse also identify the LD50 of iron (II) sulfate as 350 mg/kg, but there is no disease or death in the IPC group with doses of over 1000 mg/kg.

IPC's iron absorption is less, but IPC has better gastrointestinal intake, along with a higher IPC safety, which can be important to reduce the risk of iron overdose. Although IPC is safer than iron salts (II) inorganic, can still overdose but rare.

Symptoms of iron overdose include fatigue, nausea, vomiting, abdominal pain, stools such as darkness, fast and weak pulse, fever, coma, convulsions and death. Need emergency immediately if iron overdose. Actively monitor for timely measures.

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

Unwanted effects are classified based on frequency, including: very common (ADR ≥ 1/10); Common (1/100 ≤ ADR

The most unwanted effect on clinical reports is fading (23% of patients) due to iron elimination.

immune system disorders:

Very rare: allergic reactions.

Digestive disorders:

Very common: faded feces.

Common: diarrhea, nausea, indigestion.

Less: itching, rash.

Central neurological disorders:

Less: headache. Limit teeth dull by limiting teeth contact with drugs when taken.

With minor adverse reactions, stop using the drug the reaction will end. In case of severe sensitivity, or allergic reaction, it is necessary to conduct supportive treatment (maintain airy and use oxygen epinephrine, use antihistaminecorticoid ...).

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Oral solution Femalto is contraindicated in the following cases:

Hypersensitivity to any component of the drug.

Be cautious when using

sodium methyl parahydroxybenzoate, sodium propyl parahydroxybenzoate can cause hypersensitivity reactions, including late reactions.

If treatment fails (increasing hemoglobin about 2-3 g/dl after 3 weeks), it is necessary to reconsider the treatment.

If the patient has to repeat blood transfusion, be cautious because red blood cells can increase the amount of iron leading to iron overload.

Infections or tumors can cause anemia. Therefore, it is necessary to treat root disease and then supplement iron through oral and need to consider benefits and risks.

Using drugs for pregnant and lactating women

The product is indicated for pregnant and lactating women in cases where there is a risk of iron deficiency anemia.

The effect of drugs on driving ability, operating machinery

does not affect.

Drug interaction

Rat research does not show that the interaction between iron (III) hydroxyd polymaltose with the following drugs: tetracyclin, aluminum hydroxyd, acetylsalicylate, sulfasalazin, calcium carbonate, calcium acetate, calcium phosphate in combination with vitamin D3, bromazepam, magnesii Aspartat, D-Penicillinamin, Methyldopa, Paracetamol, Auranofin.

Similarly, there is no interaction between iron (III) Hydroxyd polymaltose with food containing phytic acid, oxalic acid, tannin, sodium alginate, cholin and cholin salts, vitamin A, vitamin D3, vitamin E, soy oil in printing studies in vitro.

Can use iron (III) Hydroxyd polymaltose during or immediately after meals.

Interaction between iron (III) Hydroxyd polymaltose and tetracyclin or hydroxyd aluminum has been evaluated through 3 human studies (cross -study, 22 patients/research). There is no significant decrease in the absorption level of tetracycline. Tetracycline concentration in plasma is sufficient to have a reduced effect. The level of iron absorption from iron (III) Hydroxyd polymaltose is also not reduced by aluminum hydroxyd and tetracycline. Therefore, iron (III) can be used simultaneously (III) of polymaltose hydroxyd with tetracyclin or phenolic compounds and aluminum salts.

Not only indicated to use the injected and femalto supplements at the same time due to oral iron absorption that can be inhibited and only used injected with inappropriate orally.

Storage

Store at a temperature not exceeding 30 ° C in the original packaging, avoid moisture and avoid light.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.